Eupraxia Pharmaceuticals is trading 10.95% higher at $7.50 in pre-market, with a broad healthcare-sector rally the likeliest explanation. - The supplied pre-market price compares with the November 4 close of $6.76; recent closes ranged from $6.76 to $7.38 between October 27 and November 4. - Healthcare is up 1.55% in pre-market; no fresh company-specific announcement explaining the move was identified. - The latest company news found was an October 22 announcement about upcoming conferences and an analyst day.